Supplementary Table S2 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Authors

Tom Schulz (ORCID: https://orcid.org/0000-0003-4070-7791)
Christoph K.W. Deinzer (ORCID: https://orcid.org/0009-0006-1961-9382)
Philipp Ivanyi (ORCID: https://orcid.org/0000-0002-2862-7302)
Sebastian Bauer (ORCID: https://orcid.org/0000-0001-5949-8120)
Adrián Mariño‐Enríquez (ORCID: https://orcid.org/0000-0002-7680-9901)
Daniel Pink (ORCID: https://orcid.org/0000-0001-7243-7373)
Valerie Haller
Peter Hohenberger (ORCID: https://orcid.org/0000-0001-5359-5923)
Peter Reichardt (ORCID: https://orcid.org/0009-0008-1410-3111)
Benjamin S. Fletcher (ORCID: https://orcid.org/0009-0000-9986-5677)
Thomas Mühlenberg (ORCID: https://orcid.org/0000-0002-2078-8857)
Johanna Falkenhorst (ORCID: https://orcid.org/0000-0002-4738-7121)
Daniel Rauh (ORCID: https://orcid.org/0000-0002-1970-7642)
Bernd Kasper (ORCID: https://orcid.org/0000-0001-8425-8356)
Rainer Hamacher (ORCID: https://orcid.org/0000-0001-9655-1226)
Yasmin Optaczy (ORCID: https://orcid.org/0009-0005-7543-5492)
Susanne Grünewald

Publication Details

Published: 2025-10-01
DOI: https://doi.org/10.1158/1078-0432.30255130
Citations: 1
Primary Topic: Gastrointestinal Tumor Research and Treatment
Type: article
Field-Weighted Citation Impact: 1.81

Supplementary Table S2 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Tom Schulz, Christoph K.W. Deinzer, Philipp Ivanyi, Sebastian Bauer, Adrián Mariño‐Enríquez, Daniel Pink, Valerie Haller, Peter Hohenberger, Peter Reichardt, Benjamin S. Fletcher, Thomas Mühlenberg, Johanna Falkenhorst, Daniel Rauh, Bernd Kasper, Rainer Hamacher, Yasmin Optaczy, Susanne Grünewald

October 1, 2025article en

1 citations

Supplementary Table S2 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Authors

Publication Details

Supplementary Table S2 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Supplementary Table S2 from Phase II Trial of Ponatinib in Patients with Metastatic Gastrointestinal Stromal Tumor following Failure or Intolerance of Prior Therapy with Imatinib (POETIG Trial)

Abstract

Ask Laika to Summarize, Analyze, and Connect papers live on the map.